Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia

• Fares Alsawah,
• Lydia Benitez,
• Sarah Choi,
• Bernard Marini,
• Anthony Perissinotti,
• Amy Skyles,
• Patrick Burke,
• Kristen Pettit,
• Ashley Crouch,
• Heather Fox,
• Dale Bixby

Affiliations

Fares Alsawah

Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI;

Lydia Benitez

Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI;

Sarah Choi

Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI

Bernard Marini

Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI;

Anthony Perissinotti

Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI;

Amy Skyles

Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI;

Patrick Burke

Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

Kristen Pettit

Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

Ashley Crouch

Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

Heather Fox

Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

Dale Bixby

Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI; Dale Bixby, Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, F4811A UH South, 1500 E Medical Center Dr, Ann Arbor, MI 48109;